|
|
cellular response to increased oxygen levels
|
GO:0036295 |
4 |
0.997
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.981
|
|
|
|
trail activated apoptotic signaling pathway
|
GO:0036462 |
4 |
0.937
|
|
|
|
skeletal muscle satellite cell proliferation
|
GO:0014841 |
1 |
0.931
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.913
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.908
|
Fly |
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.882
|
Fly |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.882
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
18 |
0.878
|
Human |
|
|
cellular response to hyperoxia
|
GO:0071455 |
4 |
0.869
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.815
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.797
|
Fly |
|
|
inflammatory response
|
GO:0006954 |
79 |
0.752
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.726
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.694
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.680
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.651
|
|
|
|
response to cobalt ion
|
GO:0032025 |
1 |
0.644
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.642
|
|
|
|
regulation of skeletal muscle cell proliferation
|
GO:0014857 |
1 |
0.611
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.609
|
Fly |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.591
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.590
|
Fly |
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.542
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.503
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.493
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.491
|
Human |
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
15 |
0.475
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.474
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.462
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
35 |
0.439
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
46 |
0.433
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.401
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
9 |
0.395
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
47 |
0.392
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
1 |
0.380
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.367
|
|
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.357
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
47 |
0.355
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.344
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.342
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
24 |
0.330
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.329
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.322
|
Human |
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.321
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.317
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.317
|
|
|
|
positive regulation of tyrosine phosphorylation of stat protein
|
GO:0042531 |
28 |
0.315
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.315
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.311
|
|
|
|
necrotic cell death
|
GO:0070265 |
21 |
0.310
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.301
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.301
|
Fly |
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.299
|
|
|
|
necroptotic process
|
GO:0070266 |
16 |
0.272
|
Human |
|
|
viral life cycle
|
GO:0019058 |
132 |
0.269
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
22 |
0.262
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.261
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.258
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.255
|
|
|
|
regulation of tyrosine phosphorylation of stat1 protein
|
GO:0042510 |
11 |
0.240
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.238
|
Rat |
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.222
|
Human |
|
|
necroptotic signaling pathway
|
GO:0097527 |
6 |
0.222
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.220
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
17 |
0.215
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.215
|
Human |
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.213
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.211
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.209
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.207
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.198
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.198
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.194
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.190
|
Human |
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.188
|
Human |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.184
|
|
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
30 |
0.183
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.182
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.181
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.178
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.177
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.173
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.170
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.167
|
Human |
|
|
positive regulation of tyrosine phosphorylation of stat1 protein
|
GO:0042511 |
8 |
0.167
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.165
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.162
|
Human |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.160
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.157
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.151
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.151
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.149
|
Human |
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
12 |
0.149
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.148
|
Human |
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.147
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.142
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.142
|
Fly |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.141
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.141
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.140
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.130
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.129
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.126
|
Human |
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.126
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.125
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.113
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.110
|
|
|
|
regulation of myoblast fusion
|
GO:1901739 |
1 |
0.110
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.110
|
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
33 |
0.109
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
2 |
0.108
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.104
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.102
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.101
|
Human |
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.099
|
Human |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.095
|
Human |
|
|
protein maturation
|
GO:0051604 |
233 |
0.094
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.093
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.089
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.085
|
Human |
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.085
|
|
|
|
negative regulation of myotube differentiation
|
GO:0010832 |
4 |
0.085
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.084
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.083
|
|
|
|
activation induced cell death of t cells
|
GO:0006924 |
2 |
0.078
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.078
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.077
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
3 |
0.077
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.077
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.073
|
Human |
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.073
|
Human |
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.071
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.067
|
Human |
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
16 |
0.067
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.066
|
Human |
|
|
thymocyte apoptotic process
|
GO:0070242 |
2 |
0.066
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.065
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.060
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.060
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.060
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.059
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
44 |
0.058
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.058
|
Human |
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.058
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.057
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.056
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.055
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.054
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.054
|
Human |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.052
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.051
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.051
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.050
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.050
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.050
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.050
|
Human |
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.050
|
Fly |
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.050
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.049
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.049
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.049
|
Human |
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.048
|
Human |
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.048
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.048
|
Human |
|
|
positive regulation of type i interferon production
|
GO:0032481 |
20 |
0.048
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.047
|
|
|
|
response to interferon beta
|
GO:0035456 |
11 |
0.047
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.047
|
Human |
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.045
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.044
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.044
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.043
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.043
|
Human |
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.043
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.042
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.042
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.042
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.041
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.041
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.040
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.040
|
|
|
|
skeletal muscle cell proliferation
|
GO:0014856 |
1 |
0.040
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.040
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
18 |
0.039
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.039
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.039
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.038
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.038
|
|
|
|
system process
|
GO:0003008 |
349 |
0.038
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.036
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.036
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.035
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.034
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.034
|
Human |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.034
|
Human |
|
|
circulatory system development
|
GO:0072359 |
262 |
0.033
|
Human |
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.033
|
|
|
|
regulation of intracellular transport of viral material
|
GO:1901252 |
2 |
0.033
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.033
|
Human |
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.032
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
10 |
0.032
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
21 |
0.032
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.032
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.032
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.032
|
Human |
|
|
blood vessel development
|
GO:0001568 |
172 |
0.031
|
Human |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.031
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.031
|
Human |
|
|
tyrosine phosphorylation of stat1 protein
|
GO:0042508 |
11 |
0.030
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.030
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.029
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.029
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.029
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.029
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.029
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.029
|
Fly |
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.028
|
Rat |
|
|
negative regulation of protein deubiquitination
|
GO:0090086 |
3 |
0.028
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.028
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.028
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.028
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.028
|
|
|
|
response to water
|
GO:0009415 |
2 |
0.028
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.028
|
Human |
|
|
striated muscle adaptation
|
GO:0014888 |
4 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.027
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.027
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.027
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.027
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
55 |
0.027
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.026
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
35 |
0.026
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.026
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.026
|
Human |
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
3 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.026
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.026
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.025
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.025
|
|
|
|
positive regulation of interferon beta production
|
GO:0032728 |
17 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.025
|
Human |
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.025
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.025
|
Human |
|
|
activated t cell proliferation
|
GO:0050798 |
13 |
0.025
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.025
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.024
|
Rat |
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.024
|
Human |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.024
|
Human |
|
|
regulation of viral genome replication
|
GO:0045069 |
48 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.024
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.024
|
Human |
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.023
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.023
|
|
|
|
spleen development
|
GO:0048536 |
1 |
0.023
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.023
|
Human |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.023
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.022
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.022
|
|
|
|
interleukin 1 production
|
GO:0032612 |
26 |
0.022
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
22 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.022
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.022
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.021
|
Human Fly |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.021
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.021
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.021
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
15 |
0.021
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.021
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.021
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.020
|
Human |
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
negative regulation of striated muscle cell differentiation
|
GO:0051154 |
8 |
0.020
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.020
|
|
|
|
positive regulation of release of cytochrome c from mitochondria
|
GO:0090200 |
18 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.019
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.019
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.019
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.019
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.019
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.019
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
1 |
0.019
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.019
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.019
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.019
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.018
|
Human |
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.018
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.018
|
Human |
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.018
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.018
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.018
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.017
|
Human |
|
|
actin filament based process
|
GO:0030029 |
224 |
0.017
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.017
|
|
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.017
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.017
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.017
|
Human |
|
|
response to metal ion
|
GO:0010038 |
84 |
0.017
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.017
|
|
|
|
fas signaling pathway
|
GO:0036337 |
3 |
0.017
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.017
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.017
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.017
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.016
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.016
|
Human |
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.016
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.016
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.016
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.016
|
Fly |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.016
|
Human |
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.016
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.016
|
Human |
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.016
|
Human |
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.016
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.016
|
Human |
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.016
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.016
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.015
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
38 |
0.015
|
Human |
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.015
|
Human |
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.015
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.015
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.015
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.015
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
16 |
0.015
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.015
|
|
|
|
negative regulation of t cell apoptotic process
|
GO:0070233 |
4 |
0.015
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
26 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.015
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.015
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.015
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.015
|
|
|
|
positive regulation of t cell migration
|
GO:2000406 |
13 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.015
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.015
|
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
2 |
0.015
|
|
|
|
regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039531 |
7 |
0.014
|
|
|
|
adaptive immune response
|
GO:0002250 |
49 |
0.014
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.014
|
Human |
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.014
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.014
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.014
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.014
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.014
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
6 |
0.014
|
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.014
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.014
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.014
|
|
|
|
interleukin 2 secretion
|
GO:0070970 |
3 |
0.014
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
29 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.013
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.013
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
2 |
0.013
|
|
|
|
basement membrane organization
|
GO:0071711 |
3 |
0.013
|
|
|
|
response to cycloheximide
|
GO:0046898 |
1 |
0.013
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
8 |
0.013
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.013
|
Human |
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.013
|
Human |
|
|
skeletal muscle organ development
|
GO:0060538 |
26 |
0.013
|
|
|
|
response to dsrna
|
GO:0043331 |
25 |
0.013
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.013
|
|
|
|
cellular response to virus
|
GO:0098586 |
9 |
0.013
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.013
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.013
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.013
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.013
|
Human |
|
|
toxin transport
|
GO:1901998 |
4 |
0.013
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.013
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.012
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
12 |
0.012
|
Human |
|
|
regulation of macrophage differentiation
|
GO:0045649 |
9 |
0.012
|
|
|
|
memory
|
GO:0007613 |
3 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.012
|
Human |
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.012
|
|
|
|
striated muscle cell development
|
GO:0055002 |
27 |
0.012
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
20 |
0.012
|
Human |
|
|
response to uv
|
GO:0009411 |
73 |
0.012
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.012
|
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
18 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.012
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.012
|
Rat |
|
|
regulation of interferon alpha production
|
GO:0032647 |
11 |
0.012
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.012
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.012
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.012
|
Human |
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
1 |
0.012
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.012
|
Human |
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.012
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.012
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.011
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.011
|
|
|
|
toll like receptor 2 signaling pathway
|
GO:0034134 |
4 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.011
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.011
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.011
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.011
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
15 |
0.011
|
|
|
|
growth
|
GO:0040007 |
202 |
0.011
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.011
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.011
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.011
|
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.011
|
|
|
|
protein autoprocessing
|
GO:0016540 |
4 |
0.010
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.010
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.010
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.010
|
|
|
|
muscle adaptation
|
GO:0043500 |
12 |
0.010
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.010
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.010
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.010
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.010
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.010
|
|
|
|
t cell differentiation
|
GO:0030217 |
29 |
0.010
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.010
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.010
|
|
|
|
positive regulation of interleukin 1 beta production
|
GO:0032731 |
13 |
0.010
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.010
|
|